Back to top
more

MEDIFAST (MED)

(Real Time Quote from BATS)

$18.46 USD

18.46
49,745

-0.14 (-0.75%)

Updated Aug 30, 2024 11:26 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

What Makes Medifast (MED) a Good Fit for "Trend Investing"

by Zacks Equity Research

Medifast (MED) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

General Mills (GIS) to Buy Tyson Foods' Pet Treats Business

by Zacks Equity Research

General Mills' (GIS) to acquire Tyson Foods' pet treats business by first-quarter fiscal 2022. The acquisition is in tandem with its Accelerate strategy.

B&G Foods (BGS) Q1 Earnings Miss Estimates, Sales Rise Y/Y

by Zacks Equity Research

B&G Foods (BGS) first-quarter fiscal 2021 results reflect higher earnings and sales on contribution from Crisco acquisition as well as persistent strength in base business net sales.

Tirthankar Chakraborty headshot

4 Must-Buy Efficient Stocks to Enrich Your Portfolio

by Tirthankar Chakraborty

Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.

Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y

by Zacks Equity Research

Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.

Vrishali Bagree headshot

Coty (COTY) Q3 Earnings Match Estimates, Revenues Decline Y/Y

by Vrishali Bagree

Coty's (COTY) third-quarter fiscal 2021 results reflect lower revenues due to the pandemic-related woes, especially in Western Europe. However, cost-saving actions aid the bottom line.

Tyson Foods (TSN) Q2 Earnings Top Estimates, Sales Up Y/Y

by Zacks Equity Research

Tyson Foods' (TSN) second-quarter 2021 sales and earnings rise year over year on revenue growth across all segments. However, inflation across supply chain is a headwind.

Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners

by Zacks Equity Research

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

TreeHouse Foods (THS) Q1 Earnings Top Estimates, Sales Miss

by Zacks Equity Research

TreeHouse Foods' (THS) first-quarter 2021 results reflect lower retail demand due to tough year-over-year comparisons and inflationary pressure.

Hain Celestial (HAIN) Q3 Earnings Beat Estimates, Sales Miss

by Zacks Equity Research

Hain Celestial's (HAIN) Q3 earnings reflect gains from improved margin performance and lower effective tax rate. It witnesses strong adjusted gross and EBITDA margin growth in the reported quarter

Post Holdings (POST) Q2 Earnings Miss, Sales Beat Estimates

by Zacks Equity Research

Post Holdings' (POST) Q2 results reflect declines in the Post Consumer Brands and Foodservice businesses. Also, comparison with last year's increased pantry-loading due to the pandemic hurt results.

The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television

by Zacks Equity Research

The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television

Sanghamitra Saha headshot

Grab These 5 Quality Stocks Screened on DuPont Analysis

by Sanghamitra Saha

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

Sejuti Banerjea headshot

5 Mid-Cap Stocks That Reported Solid Q1 Results

by Sejuti Banerjea

Diversify your portfolio to include some mid-cap stocks.

Kellogg (K) Q1 Earnings & Sales Top Estimates, Guidance Raised

by Zacks Equity Research

Kellogg's (K) first-quarter 2021 results reflect solid earnings and sales growth, along with a raised guidance for 2021. Strength in the retail business continues to aid.

Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View

by Zacks Equity Research

Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.

Medifast (MED) Moves 12.1% Higher: Will This Strength Last?

by Zacks Equity Research

Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

3 Reasons Why Medifast (MED) Is a Great Growth Stock

by Zacks Equity Research

Medifast (MED) could produce exceptional returns because of its solid growth attributes.

Medifast (MED) Stock Gains on Q1 Earnings & Revenue Beat

by Zacks Equity Research

Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.

Medifast (MED) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Medifast (MED) delivered earnings and revenue surprises of 27.21% and 18.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

ADM (ADM) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

ADM (ADM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

If You Invested $1000 in Medifast a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Kellogg (K) Lined Up for Q1 Earnings: Key Factors to Watch

by Zacks Equity Research

Kellogg's (K) first-quarter 2021 results are likely to reflect softness in the foodservice business due to weak away-from-home food demand, though at-home consumption is likely to benefit the retail business.

Nu Skin (NUS) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Efforts to strengthen sales leader and expand customer base along with benefits from product innovations are likely to get reflected in Nu Skin's (NUS) first-quarter 2021 performance.

Keurig Dr Pepper (KDP) Q1 Earnings Beat Estimates, Sales Up

by Zacks Equity Research

Keurig Dr Pepper's (KDP) first-quarter performance reflects growth across all business segments, particularly in Coffee Systems. Moreover, management raises sales view for 2021.